OpenAI Advances with Dual Focus: Targeting Healthcare and Hardware Interaction Jan 7, 2026 Life Science
Eli Lilly to Acquire Ventyx Biosciences for $1.2 Billion, Expanding Inflammation Portfolio Jan 7, 2026 Life Science
Cathie Wood’s ARK Invest Shifts 2026 Strategy, Heavily Bets on Gene Editing Technology Jan 5, 2026 Life Science
Novo Nordisk Launches Oral Weight-Loss Drug, Shifting the $100 Billion Market Landscape Jan 5, 2026 Life Science
Why Can These Two Growth Stocks Continue to Outperform the Market Until 2031? Dec 31, 2025 Life Science, Technology
Eli Lilly Plans to Acquire Abivix, Could This Deal Become a New Growth Engine? Dec 31, 2025 Life Science
Bristol-Myers Squibb Bets on the Future, Which Pipelines Will Become the New Pillars of Growth? Dec 30, 2025 Life Science
Drug Approval and Acquisition Potential Form a “Double Boost,” Providing Strong Momentum for Travere Therapeutics’ Stock Price Dec 24, 2025 Life Science
The Logic Behind Institutions’ Heavily Weighted and Counter-Cyclical Increase in Holdings of Lantheus Dec 24, 2025 Life Science
Who Will Lead the Future? Predictions for Healthcare Companies with the Greatest Growth Potential in 2026 Dec 19, 2025 Life Science
Backed by Nvidia, Recursion Soars 11% Following Bullish Analyst Call and Clinical Trial Update Dec 17, 2025 Life Science, Technology
Healthcare Supply Giant Medline Lands on Nasdaq, Raises $6.26 Billion in the Year’s Largest IPO Dec 17, 2025 Life Science
Medical Giant Medline Successfully Lands on Nasdaq, Igniting a New Wave of IPO Frenzy Dec 16, 2025 Life Science
